🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Monoclonal antibodies, such as bevacizumab, can block tumor grow...
Status
Unknown
Location
Memorial Sloan-Kettering Cancer Center
Start Date
2006-07
Trial ID
NCT00436709
RATIONALE: Drugs used in chemotherapy, such as doxorubicin, cyclophosphamid...
Status
Active Not Recruiting
Location
Regional Medical Center
Start Date
2003-11
Trial ID
NCT00070564
Treatments Being Tested
The purpose of the study is to assess the impact of first and subsequent cy...
Status
Completed
Location
Multiple Locations
Start Date
2004-05
Trial ID
NCT00125723
Treatments Being Tested
The purpose of the study is to evaluate the anti-tumor activity of LY252335...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2011-08
Trial ID
NCT01416389
Treatments Being Tested
The main purpose of this study is to see if pegfilgrastim (Neulasta) is saf...
Status
Completed
Location
Massachusetts General Hospital
Start Date
2003-07
Trial ID
NCT00146562
Treatments Being Tested
This study compares the immune response to the proposed biosimilar PF-06881...
Status
Completed
Location
Seaview A Quotient Clinical Business
Start Date
2017-10-27
Trial ID
NCT03273842
Treatments Being Tested
The study aims to compare two application forms (pre-filled syringe and On-...
Status
Completed
Location
Research Site
Start Date
2018-06-25
Trial ID
NCT03619993
Treatments Being Tested
This is a Multicenter, Double-Blind, Randomized, Comparative Efficacy and S...
Status
Completed
Location
Mylan Investigational Site 3502
Start Date
2015-03
Trial ID
NCT02467868
Open-labeled, multicenter, phase I/II study of imatinib combined with ESHAP...
Status
Unknown
Location
Dong-A University Hospital
Start Date
2015-02
Trial ID
NCT02431403
Treatments Being Tested
The study will assess the efficacy of EP2006 compared to Filgrastim with re...
Status
Completed
Location
Insitut Onkologie a Rehabilitaca na Plesi
Start Date
2011-12
Trial ID
NCT01519700
Treatments Being Tested